Literature DB >> 19265734

Risk factors for incidence of sexually transmitted infections among women in South Africa, Tanzania, and Zambia: results from HPTN 055 study.

Saidi Kapiga1, Cliff Kelly, Stephen Weiss, Tara Daley, Leigh Peterson, Corey Leburg, Gita Ramjee.   

Abstract

OBJECTIVE: To determine risk factors for sexually transmitted infections (STIs) among women in Durban and Hlabisa (South Africa), Moshi (Tanzania), and Lusaka (Zambia). STUDY
DESIGN: Between 2003 and 2004, 958 women at risk of STIs were enrolled in a 1-year prospective study. They were interviewed at each monthly visit, and samples for STI testing were collected during quarterly and other visits when clinically indicated.
RESULTS: The incidence of infections as measured in person-years at risk (PYAR) was as follows: overall trichomoniasis, 31.9/100 PYAR; chlamydial infection in South Africa, 19.5/100 PYAR; chlamydial infection in Tanzania and Zambia, 4.9/100 PYAR; gonorrhea in South Africa, 16.5/100 PYAR; gonorrhea in Tanzania and Zambia, 5.3/100 PYAR; overall syphilis, 7.5/100 PYAR; and overall HIV, 3.8/100 PYAR. The incidence of most STIs was highest among the South African sites, where chlamydial infection and gonorrhea were detected by using a more sensitive assay. Independent risk factors included age, hormonal contraceptive methods, and measures of sexual behavior, including number of sex partners and occurrence of anal sex in the past 3 months. Women with incident HIV infection were at increased risk of chlamydial infection [odds ratio (OR) = 5.5, 95% confidence interval (CI): 2.0-15.2]and gonorrhea (OR = 5.7, 95% CI: 1.9-17.0) in South African sites. Despite ongoing counseling during the study, high-risk sexual behaviors were common, and consistent condom use remained low.
CONCLUSIONS: The incidence of STIs, including HIV, was high among women in this study. These findings highlight the urgent need for effective HIV/STI prevention programs in this population.

Entities:  

Mesh:

Year:  2009        PMID: 19265734     DOI: 10.1097/OLQ.0b013e318191ba01

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  18 in total

1.  Targeted Pregnancy and Human Immunodeficiency Virus Prevention Risk-Reduction Counseling for Young Women: Lessons Learned from Biomedical Prevention Trials.

Authors:  Gita Ramjee; Reshmi Dassaye; Tarylee Reddy; Handan Wand
Journal:  J Infect Dis       Date:  2018-10-20       Impact factor: 5.226

2.  Bacterial vaginosis and the risk of trichomonas vaginalis acquisition among HIV-1-negative women.

Authors:  Jennifer E Balkus; Barbra A Richardson; Lorna K Rabe; Taha E Taha; Nyaradzo Mgodi; Margaret Phiri Kasaro; Gita Ramjee; Irving F Hoffman; Salim S Abdool Karim
Journal:  Sex Transm Dis       Date:  2014-02       Impact factor: 2.830

3.  Alcohol, Drug and Sexual Risk Behavior Correlates of Recent Transactional Sex Among Female Black South African Drug Users.

Authors:  Sarra L Hedden; Alicia Hulbert; Courtenay E Cavanaugh; Charles D Parry; Anne Gloria Moleko; William W Latimer
Journal:  J Subst Use       Date:  2011-02

4.  Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial.

Authors:  Lynette J Menezes; Ubin Pokharel; Staci L Sudenga; Matthys H Botha; Michele Zeier; Martha E Abrahamsen; Richard H Glashoff; Susan Engelbrecht; Maarten F Schim van der Loeff; Louvina E van der Laan; Siegfried Kipping; Douglas Taylor; Anna R Giuliano
Journal:  Sex Transm Infect       Date:  2017-05-10       Impact factor: 3.519

5.  Risk Factors for Incidence of Sexually Transmitted Infections Among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003).

Authors:  Zvavahera Mike Chirenje; Holly M Gundacker; Barbra Richardson; Lorna Rabe; Zakir Gaffoor; Gonasagrie Lulu Nair; Brenda Gati Mirembe; Jeanna M Piper; Sharon Hillier; Jeanne Marrazzo
Journal:  Sex Transm Dis       Date:  2017-03       Impact factor: 2.830

6.  Prevalence and associations with hepatitis B and hepatitis C infection among HIV-infected adults in South Africa.

Authors:  C J Hoffmann; D Dayal; M Cheyip; J A McIntyre; G E Gray; S Conway; N A Martinson
Journal:  Int J STD AIDS       Date:  2012-10       Impact factor: 1.359

7.  HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women.

Authors:  M Bradford Guffey; Barbra Richardson; Marla Husnik; Bonus Makanani; David Chilongozi; Elmer Yu; Gita Ramjee; Nyaradzo Mgodi; Kailazarid Gomez; Sharon L Hillier; Salim Abdool Karim
Journal:  Sex Transm Infect       Date:  2014-06-04       Impact factor: 3.519

8.  A qualitative study of discourses on heterosexual anal sexual practice among key, and general populations in Tanzania: implications for HIV prevention.

Authors:  Joyce Wamoyi; Aika Mongi; Mtenga Sally; Deodatus Kakoko; Donat Shamba; Eveline Geubbels; Saidi Kapiga
Journal:  BMC Public Health       Date:  2015-04-24       Impact factor: 3.295

9.  Epidemiology of curable sexually transmitted infections among women at increased risk for HIV in northwestern Tanzania: inadequacy of syndromic management.

Authors:  Suzanna C Francis; Trong T Ao; Fiona M Vanobberghen; Joseph Chilongani; Ramadhan Hashim; Aura Andreasen; Deborah Watson-Jones; John Changalucha; Saidi Kapiga; Richard J Hayes
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

10.  High prevalence and incidence of sexually transmitted infections among women living in Kwazulu-Natal, South Africa.

Authors:  Sarita Naidoo; Handan Wand; Nathlee Samantha Abbai; Gita Ramjee
Journal:  AIDS Res Ther       Date:  2014-09-15       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.